We found that 84.8% (28/33) were positive for methylation, whereas only 15.2% (5/33) did not show methylation (Figure 1B), indicating that methylation in the promoter region of caveolin-1 was prevalent among HBV-infected HCC patients. Here, CAV1 is linked to hepatocellular carcinoma.